Wegovy® Cost Without Insurance & Savings Guide (2026)

What is Wegovy?

Wegovy® (semaglutide 2.4 mg) is a prescription GLP-1 receptor agonist manufactured by Novo Nordisk. It is FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Wegovy is also approved to reduce the risk of cardiovascular events in adults with established cardiovascular disease and obesity or overweight.

Who uses Wegovy?

• Adults with a BMI of 30 or higher (obesity) — As an addition to a reduced-calorie diet and increased physical activity.
• Adults with a BMI of 27 or higher with a weight-related health condition — Including type 2 diabetes, hypertension, or dyslipidemia.
• Adults with cardiovascular disease and obesity/overweight — Based on the SELECT trial, Wegovy reduces the risk of heart attack, stroke, and cardiovascular death by 20% in this population.
• Adolescents aged 12+ with obesity — Wegovy is approved for pediatric use in certain cases.

Wegovy is administered as a once-weekly subcutaneous injection using a prefilled pen. The dosing schedule starts at 0.25 mg weekly and escalates over 16–20 weeks to the maintenance dose of 2.4 mg weekly.

What Does Wegovy Cost Without Insurance?

"How much does Wegovy actually cost?" It's the question behind every search — and the answer is a genuine shock. Without any savings program, you're looking at a monthly cost that exceeds many people's car payment. And because many insurance plans still classify weight management medications as "lifestyle" drugs and exclude them, a surprisingly large number of patients face this full price.

Why is Wegovy so expensive?

• It's a biologic in a new drug class: Wegovy is a bioengineered injectable peptide — manufacturing costs are far higher than traditional pills. Additionally, GLP-1 agonists for weight management are a relatively new category with limited competition.
• No generic or biosimilar available: No FDA-approved generic or biosimilar for semaglutide 2.4 mg exists as of 2026, and none is expected for several years.
• Many plans exclude it: Because anti-obesity medications are still classified as "lifestyle" by many insurers, a significant number of plans simply don't cover Wegovy at all — leaving patients to pay the full list price if they want to use it.
• Supply constraints: High demand and manufacturing limitations have periodically led to shortages, keeping prices elevated.

The WegoTogether™ Savings Program

Novo Nordisk offers the WegoTogether™ savings program for eligible commercially insured patients prescribed Wegovy.

What you can save

• Eligible patients may pay a reduced copay on their Wegovy prescriptions.
• The exact savings amount depends on your insurance plan's coverage and the current program terms set by Novo Nordisk.
• Savings are applied at the point of sale at participating pharmacies.

Who qualifies?

• You must have commercial health insurance that covers Wegovy.
• You must have a valid prescription for Wegovy for an FDA-approved indication.
• You must be a U.S. resident.
• You must not be enrolled in Medicare, Medicaid, CHIP, TRICARE, or any other government program.

Key program details

• Present the savings card at each fill. Pharmacies typically do not apply it automatically — you need to proactively provide the card number.
• Wegovy can be filled at most retail pharmacies (CVS, Walgreens, Walmart, etc.) and specialty pharmacies.
• Program terms, including maximum benefit amounts, are set by Novo Nordisk and may change. Verify current terms at enrollment.

Step-by-Step: How to Get Wegovy Savings

This process has more variables than most drugs because insurance coverage for weight management medications is inconsistent. Follow these steps carefully — the order matters.

1. Check whether your insurance covers Wegovy

   Before anything else, call the member services number on the back of your insurance card and ask: "Does my plan cover Wegovy (semaglutide 2.4 mg) for chronic weight management?" If the answer is no, ask whether there is a formulary exception process. Many patients are initially told they're not covered when an exception request could change that.

2. Get your prescription and start prior authorization

   If your insurance covers Wegovy (or you're pursuing an exception), your doctor needs to submit a prior authorization. For weight management, the PA typically requires documentation of BMI, previous weight loss attempts, and any weight-related health conditions. This step can take 1–4 weeks. Be proactive — PA delays are the most common bottleneck.

3. Enroll in WegoTogether

   Visit wegovy.com/savings-and-support or call NovoCare at 1-888-693-8276. Enrollment takes a few minutes. Have your insurance information and prescription details ready.

4. Confirm stock availability before filling

   Wegovy has experienced supply issues. Before your pharmacy processes the prescription, call them to confirm they have the correct dose in stock. Ask NovoCare for help locating pharmacies with current inventory if yours is out of stock.

5. Present the savings card at the pharmacy

   Give your pharmacist the WegoTogether card information before they process the claim. Confirm the final price reflects the discount. If the price seems wrong, do not pay — ask them to reprocess or call NovoCare for help while at the counter.

Medicare, Medicaid & Uninsured: Your Options

If the WegoTogether savings card isn't available to you — either because you have government insurance or because your plan doesn't cover Wegovy — here are the real alternatives.

If you have Medicare

• Wegovy for cardiovascular risk reduction: If you have established cardiovascular disease, your doctor may be able to prescribe Wegovy under its cardiovascular indication rather than weight management. Some Medicare Part D plans cover Wegovy for this specific use case. Ask your doctor and plan about this option.
• Patient Assistance Program: Novo Nordisk offers a PAP for qualifying uninsured or underinsured patients. Medicare patients may qualify depending on circumstances — call NovoCare at 1-888-693-8276 to check eligibility.
• State pharmaceutical assistance programs: Some states offer supplemental drug assistance for Medicare beneficiaries. Check with your State Health Insurance Assistance Program (SHIP) at shiphelp.org.

If you're uninsured

How to apply for the PAP

The application requires more paperwork than the savings card, but patients who meet the income threshold are generally approved — and the outcome is complete coverage: free medication, not just a discount.

1. Download the application at novocare.com or request one by phone.
2. Gather documentation: proof of income, U.S. residency, and insurance status.
3. Have your doctor complete their section of the application.
4. Submit and wait 5–15 business days for processing.
5. Renew annually — set a 60-day advance reminder.

Other resources

• NeedyMeds.org: Search "Wegovy" at needymeds.org.
• ACA Marketplace: If you're uninsured, marketplace plans at healthcare.gov may cover Wegovy — coverage varies by plan and state.

What to Do at the Pharmacy (If Something Goes Wrong)

Even with everything in order, Wegovy fills can hit snags. If your price is still high, it usually comes down to one of three issues: the savings card wasn't applied, a prior authorization is missing, or your insurance doesn't cover the drug.

If the price is unexpectedly high

Ask the pharmacist: "Was my WegoTogether savings card applied to this fill?" Give them the card information and ask them to reprocess. If the card was applied and the price is still high, the issue is likely on the insurance side — the copay card can only reduce what insurance leaves you to pay.

If the pharmacy says Wegovy is out of stock

This has been a persistent issue. Ask the pharmacy to check when they expect the next shipment. Call NovoCare (1-888-693-8276) to find nearby pharmacies with inventory. Do not substitute compounded semaglutide — it is not FDA-approved and has a different safety profile.

If your insurance denies coverage

Coverage denials for weight management drugs are common — more common than for most medications on this site. But a denial is not always the final word:

• Ask your doctor to submit a formulary exception request with documentation of your weight-related conditions and failed prior interventions.
• If denied, consider the cardiovascular indication — if you have established heart disease, coverage under that indication may be possible.
• If your plan categorically excludes weight loss drugs, consider switching plans during open enrollment to one that covers anti-obesity medications. Coverage challenges are common across GLP-1 drugs — see our guides for Zepbound and Mounjaro if your doctor is considering alternatives.

If you already paid full price

Call the pharmacy within 14 days and ask them to reverse and rebill with your savings card. If the pharmacy can't help, call NovoCare.

Common Mistakes (and How to Avoid Them)

• Not checking coverage before getting the prescription.
  Many plans exclude anti-obesity medications entirely. If you get a prescription, go through prior authorization, and then discover your plan doesn't cover Wegovy, you've lost weeks. Call your insurance first.
• Assuming the savings card works without insurance coverage.
  The WegoTogether card reduces your copay on a covered prescription. If Wegovy isn't covered by your plan, there is no copay to reduce — the card won't work. This is how all manufacturer copay cards function — see how copay cards work for the complete explanation.
• Using compounded semaglutide to save money.
  Compounded versions are not FDA-approved, are not equivalent to Wegovy, and have been linked to safety concerns. They also don't qualify for manufacturer savings programs.
• Not presenting the savings card at every fill.
  Pharmacies almost never apply it automatically. Keep the card number on your phone and provide it every time.
• Giving up after the first denial.
  Insurance denials for weight management drugs are extremely common on first pass. Many patients walk away not realizing that a letter of medical necessity from their doctor often reverses the decision. Always file at least one appeal.
• Ignoring copay accumulator policies.
  Some plans don't count savings card payments toward your deductible. Ask your insurer: "Does my plan use a copay accumulator?" For more, see our copay accumulator explainer.

Pro Tips to Maximize Your Savings

• Check the cardiovascular indication.
  If you have established heart disease, Wegovy's SELECT trial data may support coverage under the cardiovascular risk reduction indication — which some plans cover even when they exclude weight loss drugs. This strategy also applies to cardiovascular drugs like Repatha.
• Ask about the dose escalation schedule at enrollment.
  Wegovy requires a 16–20 week titration from 0.25 mg to 2.4 mg. Lower-dose pens during titration may cost less. Confirm pricing at each dose level.
• Use NovoCare for insurance navigation.
  NovoCare (1-888-693-8276) has specialists who help with prior authorization, appeals, and coverage questions. This is a free service — use it.
• Compare plans during open enrollment.
  Anti-obesity medication coverage varies enormously between plans. If your current plan excludes Wegovy, you may be able to switch to one that covers it — and the savings over a year can be enormous.
• Document everything for appeals.
  Keep copies of your BMI measurements, weight history, prior diet/exercise attempts, comorbidity diagnoses, and any specialist referrals. This documentation makes appeals significantly more likely to succeed. Our guide to reducing prescription costs covers additional strategies beyond appeals.

Wegovy Savings: Frequently Asked Questions

Related Resources

Getting Wegovy at a price you can afford takes more work than most drugs — but for patients who qualify, the savings can be life-changing. You've already taken the first step by understanding your options.